Diagnostic challenges for multiplexed protein microarrays.

Multiplexed protein analysis using planar microarrays or microbeads is growing in popularity for simultaneous assays of antibodies, cytokines, allergens, drugs and hormones. However, this new assay format presents several new operational issues for the clinical laboratory, such as the quality control of protein-microarray-based assays, the release of unrequested test data and the use of diagnostic algorithms to transform microarray data into diagnostic results.

[1]  Peter E. Barker,et al.  Cancer Biomarker Validation: Standards and Process , 2003 .

[2]  H. Dutertre-Catella,et al.  Automated liquid-chromatographic analyzer used for toxicology screening in a general hospital: 12 months' experience. , 1997, Clinical chemistry.

[3]  Ruo-Pan Huang,et al.  Detection of Multiple Cytokines by Protein Arrays from Cell Lysate and Tissue Lysate , 2003, Clinical chemistry and laboratory medicine.

[4]  J O Westgard,et al.  A multi-rule Shewhart chart for quality control in clinical chemistry. , 1981, Clinical chemistry.

[5]  John P Nolan,et al.  Suspension array technology: evolution of the flat-array paradigm. , 2002, Trends in biotechnology.

[6]  M. W. Mueller,et al.  Microarrayed recombinant allergens for diagnosis of allergy , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  M. Brandileone,et al.  Validation of a Multiplex Pneumococcal Serotyping Assay with Clinical Samples , 2006, Journal of Clinical Microbiology.

[8]  D Haussler,et al.  Knowledge-based analysis of microarray gene expression data by using support vector machines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Christian Harwanegg,et al.  Protein microarrays for the diagnosis of allergic diseases: state-of-the-art and future development , 2006, Clinical chemistry and laboratory medicine.

[10]  Y. Shoenfeld,et al.  Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases , 2005, Autoimmunity.

[11]  Jing Yin,et al.  Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. , 2002, Cancer research.

[12]  R. Ekins,et al.  Ligand assays: from electrophoresis to miniaturized microarrays. , 1998, Clinical chemistry.

[13]  Sayan Mukherjee,et al.  Molecular classification of multiple tumor types , 2001, ISMB.

[14]  A. B. Robinson,et al.  Sex-related patterns in the profiles of human urinary amino acids. , 1975, Clinical chemistry.

[15]  Paul Bertone,et al.  Advances in functional protein microarray technology , 2005, The FEBS journal.

[16]  Peter A Benn,et al.  Advances in prenatal screening for Down syndrome: I. general principles and second trimester testing. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[17]  Mark Schena,et al.  Microarray Biochip Technology , 2000 .

[18]  B. Nahm,et al.  Quantitative measurement of serum allergen-specific IgE on protein chip , 2002, Experimental & Molecular Medicine.

[19]  Mark C. Genovese,et al.  Computer-Assisted Pattern Recognition of Autoantibody Results , 2005, Clinical Diagnostic Laboratory Immunology.

[20]  John V Lamont,et al.  Development of a high-throughput automated analyzer using biochip array technology. , 2005, Clinical chemistry.

[21]  Reinhard Niessner,et al.  Microarrays for the screening of allergen-specific IgE in human serum. , 2003, Analytical chemistry.

[22]  Stefan Müllner,et al.  Protein biochips: A new and versatile platform technology for molecular medicine. , 2005, Drug discovery today.

[23]  Stephen R Master,et al.  Validation and quality control of protein microarray-based analytical methods. , 2005, Methods in molecular medicine.

[24]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. P. Fodor,et al.  High density synthetic oligonucleotide arrays , 1999, Nature Genetics.

[26]  M. W. Mueller,et al.  Allergen microarray: comparison of microarray using recombinant allergens with conventional diagnostic methods to detect allergen‐specific serum immunoglobulin E , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[27]  Lynn Wagner.  A test before its time? FDA stalls distribution process of proteomic test. , 2004, Journal of the National Cancer Institute.

[28]  R. Huang,et al.  Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system. , 2001, Analytical biochemistry.

[29]  E. Southern,et al.  DNA microarrays. History and overview. , 2001, Methods in molecular biology.

[30]  Susan M Varnum,et al.  Studying Cellular Processes and Detecting Disease with Protein Microarrays , 2005, Drug metabolism reviews.

[31]  J. Mesirov,et al.  Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Angenendt.  Progress in protein and antibody microarray technology. , 2005, Drug discovery today.

[33]  C. Hixson,et al.  Protein arrays and pattern recognition: new tools to assist in the identification and management of autoimmune disease. , 2006, Autoimmunity reviews.

[34]  Dieter Stoll,et al.  Protein microarrays: applications and future challenges. , 2005, Current opinion in drug discovery & development.